Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tingwenli Huang"'
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Cancer drug resistance has always been a major factor affecting the treatment of non-small cell lung cancer, which reduces the quality of life of patients. The clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRI
Externí odkaz:
https://doaj.org/article/a9a7d1107ded44899aecc1b40be11f51
Autor:
Yan Chen, TaiPeng Shen, LiJun Zhong, ZhiXi Liu, XinWei Dong, TingWenLi Huang, QiuJu Wang, HongTao Xiao
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
In December 2019, a severe outbreak of a novel coronavirus (COVID-19) occurred in the whole world, posing a great threat to people’s health. With the outbreak and development of the epidemic, how to improve the cure rate, find effective drugs again
Externí odkaz:
https://doaj.org/article/e69a15156fed4b61b5a6337e7bd2f7ee
Autor:
Yan Chen, Rui Zhang, Dandan Mi, Qiuju Wang, Tingwenli Huang, Xinwei Dong, Hongwei Zhang, Hongtao Xiao, Sanjun Shi
Publikováno v:
Gastric Cancer. 26:26-43
Imatinib mesylate (IM) is highly effective in the treatment of gastrointestinal stromal tumors (GISTs). However, the most of GISTs patients develop secondary drug resistance after 1-3 years of IM treatment. The aim of this study was to explore the IM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb80d96f9f00c3d44deb261f3705da75
https://doi.org/10.1007/s10120-022-01332-7
https://doi.org/10.1007/s10120-022-01332-7
Autor:
Sanjun Shi, Chen Yan, Tingwenli Huang, QiuJu Wang, Xiao Hongtao, Rui Zhang, Xinwei Dong, Ying Jia, Ma Hongli
Imatinib mesylate (IM) is highly efficacious in the treatment of gastrointestinal stromal tumors (GISTs). Therapeutic drug monitoring (TDM) and pharmacogenetic screening are affirmed for better management of IM therapy. The goal of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0ae3dd0b6454303ab79e0b599c05cc0
https://doi.org/10.21203/rs.3.rs-739965/v1
https://doi.org/10.21203/rs.3.rs-739965/v1
：In the 1960 of the 20th century, scientists firstly advanced the concept of using gene therapy to cure the human genetic disease, which aimed to carry out precisely site-specific modification on the genome for obtain long-term therapeutic effect i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce077a4bf8fc3901e9c5a2c2f4ff2c81
https://doi.org/10.22541/au.160386849.91786201/v1
https://doi.org/10.22541/au.160386849.91786201/v1
Autor:
Tingwenli Huang, Yichun Jiang, Tianyu Chen, Huimin Sun, Qian Yang, Ningxi Li, Yan Chen, Min Wu, Xiaoyan Yan
Objective: A polymer-based nanoparticle was constructed to target sorafenib delivery to colorectal carcinoma cells and decrease the side effects of the drug. Methods: Sorafenib-loaded nanoparticles (S-NPs) based on PEG-PLGA were prepared using a doub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471a7d208461ccd0b4cebe12d65c9b9a
Autor:
Chen, Yan, Zhang, Rui, Mi, Dandan, Wang, Qiuju, Huang, Tingwenli, Dong, Xinwei, Zhang, Hongwei, Xiao, Hongtao, Shi, Sanjun
Publikováno v:
Gastric Cancer; Jan2023, Vol. 26 Issue 1, p26-43, 18p
Decreasing acute toxicity and suppressing colorectal carcinoma using Sorafenib-loaded nanoparticles.
Autor:
Li, Ningxi1 (AUTHOR), Chen, Yan2 (AUTHOR), Sun, Huimin1 (AUTHOR), Huang, Tingwenli1 (AUTHOR), Chen, Tianyu1 (AUTHOR), Jiang, Yichun1 (AUTHOR), Yang, Qian1 (AUTHOR), Yan, Xiaoyan1 (AUTHOR), Wu, Min1 (AUTHOR) wuminzhaofeng@126.com
Publikováno v:
Pharmaceutical Development & Technology. Jun2020, Vol. 25 Issue 5, p556-565. 10p.
Publikováno v:
Frontiers in Pharmacology; 5/10/2022, Vol. 13, p1-13, 13p
Autor:
Chen, Yan, Shen, TaiPeng, Zhong, LiJun, Liu, ZhiXi, Dong, XinWei, Huang, TingWenLi, Wang, QiuJu, Xiao, HongTao
Publikováno v:
Frontiers in Pharmacology; 7/31/2020, Vol. 11, pN.PAG-N.PAG, 13p